This Fusion Animation explores the Genetic Pathways in NASH progression. We detail key risk factors, including the $PNPLA3$ and $TM6SF2$ variants. Crucially, the animation focuses on HSD17B13, a promising therapeutic modulation target. We visualize how disease-protective variants suggest that reducing HSD17B13 expression can halt fibrosis. This showcases our expertise in Hepatology, Genetic Disease, and Drug Target MOA concepts.
Hepatic Medical Animations
Capture complex hepatic science with stunning 3D animation and masterful scientific storytelling.

NASH PATHOPHYSIOLOGY: GENETIC TARGETS AND THE ROLE OF HSD17B13 IN FIBROSIS
This Fusion Animation explores the Genetic Pathways in NASH progression. We detail key risk factors, including the $PNPLA3$ and $TM6SF2$ variants. Crucially, the animation focuses on HSD17B13, a promising therapeutic modulation target. We visualize how disease-protective variants suggest that reducing HSD17B13 expression can halt fibrosis. This showcases our expertise in Hepatology, Genetic Disease, and Drug Target MOA concepts.







